Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

ScinoPharm Taiwan, Ltd. (1789.TW)

Taiwan - Taiwan Delayed Price. Currency in TWD
26.75-0.10 (-0.37%)
At close: 01:30PM CST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in TWD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 2/3/2023
Current
9/30/20226/30/20223/31/202212/31/2021
Market Cap (intraday)
21.19B19.45B20.36B18.42B19.49B
Enterprise Value
17.54B15.68B16.77B14.85B16.23B
Trailing P/E
68.7276.8885.8375.1698.60
Forward P/E
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/A
Price/Sales (ttm)
7.166.687.136.686.69
Price/Book (mrq)
2.041.871.911.751.89
Enterprise Value/Revenue
5.9122.2520.8120.1222.56
Enterprise Value/EBITDA
21.7679.9666.2276.7799.33

Trading Information

Stock Price History

Beta (5Y Monthly) 0.42
52-Week Change 312.11%
S&P500 52-Week Change 3-9.23%
52 Week High 329.65
52 Week Low 322.35
50-Day Moving Average 325.45
200-Day Moving Average 325.05

Share Statistics

Avg Vol (3 month) 32.02M
Avg Vol (10 day) 31.35M
Shares Outstanding 5790.74M
Implied Shares Outstanding 6N/A
Float 8214.92M
% Held by Insiders 158.97%
% Held by Institutions 116.87%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.48
Forward Annual Dividend Yield 41.79%
Trailing Annual Dividend Rate 30.48
Trailing Annual Dividend Yield 31.79%
5 Year Average Dividend Yield 41.61
Payout Ratio 4123.08%
Dividend Date 3N/A
Ex-Dividend Date 4Jul 07, 2022
Last Split Factor 21040:1000
Last Split Date 3Aug 10, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2021
Most Recent Quarter (mrq)Sep 30, 2022

Profitability

Profit Margin 10.29%
Operating Margin (ttm)11.52%

Management Effectiveness

Return on Assets (ttm)1.84%
Return on Equity (ttm)2.95%

Income Statement

Revenue (ttm)2.97B
Revenue Per Share (ttm)3.75
Quarterly Revenue Growth (yoy)7.70%
Gross Profit (ttm)1.28B
EBITDA 743.66M
Net Income Avi to Common (ttm)305.35M
Diluted EPS (ttm)0.39
Quarterly Earnings Growth (yoy)585.70%

Balance Sheet

Total Cash (mrq)4.25B
Total Cash Per Share (mrq)5.37
Total Debt (mrq)648.05M
Total Debt/Equity (mrq)6.23
Current Ratio (mrq)8.97
Book Value Per Share (mrq)13.15

Cash Flow Statement

Operating Cash Flow (ttm)847.36M
Levered Free Cash Flow (ttm)521.95M
Advertisement
Advertisement